Related Experiment Video
Updated: Jun 5, 2026

Venous Thrombosis Assay in a Mouse Model of Cancer
Published on: January 5, 2024
Pernicious Anemia Presenting as Pseudo-Thrombotic Microangiopathy: A Case Report
Sai Sushrutha Mudupula Vemula1,2, Shreeya Adhikari2, Shreya Motkur2
1Internal Medicine, Michigan State University, East Lansing, USA.
Abstract:
Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening thrombotic microangiopathy (TMA) characterized by microangiopathic hemolytic anemia, thrombocytopenia, and end-organ dysfunction, with high untreated mortality that can be effectively reduced with timely plasma exchange (PLEX) and immunosuppressive therapy. However, several conditions can produce a clinically similar pseudo-TMA picture, among which severe vitamin B12 deficiency is an underrecognized and potentially treatable mimic that occurs due to ineffective intramedullary erythropoiesis, megaloblastic fragmentation of structurally abnormal erythrocytes, and pancytopenia in the absence of true endothelial injury or ADAMTS13 deficiency. We present a 74-year-old female patient who presented with altered mental status, bradycardia, and severe hemolytic anemia, in whom PLEX was initiated for suspected TTP but failed to improve platelet counts despite four sessions, ultimately prompting a workup that showed B12 deficiency due to pernicious anemia, confirmed by an elevated methylmalonic acid (MMA) and low serum B12, with complete hematologic recovery following cyanocobalamin repletion.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Venous Thrombosis I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetic Retinopathy